Annual Total Liabilities
$825.90 K
-$4.55 M-84.64%
December 1, 2023
Summary
- As of February 7, 2025, XRTX annual total liabilities is $825.90 thousand, with the most recent change of -$4.55 million (-84.64%) on December 1, 2023.
- During the last 3 years, XRTX annual total liabilities has risen by +$14.90 thousand (+1.84%).
- XRTX annual total liabilities is now -84.64% below its all-time high of $5.38 million, reached on December 31, 2022.
Performance
XRTX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$1.72 M
-$377.80 K-18.04%
September 1, 2024
Summary
- As of February 7, 2025, XRTX quarterly total liabilities is $1.72 million, with the most recent change of -$377.80 thousand (-18.04%) on September 1, 2024.
- Over the past year, XRTX quarterly total liabilities has increased by +$890.90 thousand (+107.87%).
- XRTX quarterly total liabilities is now -81.86% below its all-time high of $9.46 million, reached on September 1, 2021.
Performance
XRTX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
XRTX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -84.6% | +107.9% |
| 3 y3 years | +1.8% | +186.2% |
| 5 y5 years | +19.2% | +186.2% |
XRTX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -84.6% | at low | -68.1% | +325.7% |
| 5 y | 5-year | -84.6% | +1.8% | -81.9% | +325.7% |
| alltime | all time | -84.6% | >+9999.0% | -81.9% | >+9999.0% |
XORTX Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.72 M(-18.0%) |
| Jun 2024 | - | $2.09 M(-41.2%) |
| Mar 2024 | - | $3.56 M(+331.0%) |
| Dec 2023 | $825.90 K(-84.6%) | $825.90 K(+49.1%) |
| Sep 2023 | - | $553.80 K(+37.3%) |
| Jun 2023 | - | $403.30 K(-32.8%) |
| Mar 2023 | - | $599.80 K(-88.8%) |
| Dec 2022 | $5.38 M(+28.7%) | $5.38 M(+72.9%) |
| Sep 2022 | - | $3.11 M(+5.4%) |
| Jun 2022 | - | $2.95 M(-26.9%) |
| Mar 2022 | - | $4.04 M(-3.4%) |
| Dec 2021 | $4.18 M(+415.3%) | - |
| Dec 2021 | - | $4.18 M(-55.8%) |
| Sep 2021 | - | $9.46 M(+192.4%) |
| Jun 2021 | - | $3.24 M(-14.5%) |
| Mar 2021 | - | $3.78 M(+366.6%) |
| Dec 2020 | $811.00 K(-18.5%) | $811.00 K(+9.2%) |
| Sep 2020 | - | $743.00 K(+16.5%) |
| Jun 2020 | - | $637.60 K(-22.7%) |
| Mar 2020 | - | $825.00 K(-17.1%) |
| Dec 2019 | $995.00 K | $995.00 K(+11.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $889.10 K(+9.5%) |
| Jun 2019 | - | $812.20 K(+12.3%) |
| Mar 2019 | - | $723.40 K(+4.4%) |
| Dec 2018 | $692.90 K(-23.9%) | $692.90 K(-0.2%) |
| Sep 2018 | - | $694.00 K(+10.1%) |
| Jun 2018 | - | $630.10 K(-1.0%) |
| Mar 2018 | - | $636.40 K(-30.1%) |
| Dec 2017 | $910.70 K(+8741.7%) | $910.70 K(>+9900.0%) |
| Nov 2017 | - | $6200.00(-99.1%) |
| Sep 2017 | - | $688.90 K(>+9900.0%) |
| Aug 2017 | - | $5600.00(-16.4%) |
| May 2017 | - | $6700.00(-35.0%) |
| Feb 2017 | $10.30 K(-97.7%) | $10.30 K(+49.3%) |
| Dec 2016 | $446.00 K(+7093.5%) | - |
| Nov 2016 | - | $6900.00(-86.5%) |
| Aug 2016 | - | $51.30 K(+216.7%) |
| May 2016 | - | $16.20 K(+161.3%) |
| Feb 2016 | $6200.00(-87.1%) | $6200.00(-1.6%) |
| Nov 2015 | - | $6300.00(-93.7%) |
| Aug 2015 | - | $99.90 K(+43.9%) |
| May 2015 | - | $69.40 K(+44.3%) |
| Feb 2015 | $48.10 K | $48.10 K |
FAQ
- What is XORTX Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for XORTX Therapeutics?
- What is XORTX Therapeutics annual total liabilities year-on-year change?
- What is XORTX Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for XORTX Therapeutics?
- What is XORTX Therapeutics quarterly total liabilities year-on-year change?
What is XORTX Therapeutics annual total liabilities?
The current annual total liabilities of XRTX is $825.90 K
What is the all time high annual total liabilities for XORTX Therapeutics?
XORTX Therapeutics all-time high annual total liabilities is $5.38 M
What is XORTX Therapeutics annual total liabilities year-on-year change?
Over the past year, XRTX annual total liabilities has changed by -$4.55 M (-84.64%)
What is XORTX Therapeutics quarterly total liabilities?
The current quarterly total liabilities of XRTX is $1.72 M
What is the all time high quarterly total liabilities for XORTX Therapeutics?
XORTX Therapeutics all-time high quarterly total liabilities is $9.46 M
What is XORTX Therapeutics quarterly total liabilities year-on-year change?
Over the past year, XRTX quarterly total liabilities has changed by +$890.90 K (+107.87%)